| The 20th century, with China's WTO accession, enterprises operating environment has undergone great changes, a series of internal management of the new policy introduced medicine, and foreign pharmaceutical enterprises gain access to China, and China's pharmaceutical enterprises inevitably to join the international and domestic economic competition medicine. My fierce competition in the pharmaceutical enterprises to seek survival and development is the top priority of enterprises. The first of the current status and development of the pharmaceutical industry analysed the characteristics of China's pharmaceutical industry and a review of problems, a comprehensive analysis of the pharmaceutical companies and the external environment facing competitive posture, reflect the core competitiveness of enterprises from the associated elements with, using relevant theoretical analysis given the Jilin Pharmaceutical Company, Ltd. core competitiveness overall evaluation. The analysis of the Chinese pharmaceutical industry restructuring opportunities and threats for the pharmaceutical industry trends forward-looking analysis done on the basis of a clearer Jilin Pharmaceutical Company, Ltd. of development goals and strategic choice: the implementation of market demand-oriented, based on the core competitiveness of technological innovation strategy to achieve sustained competitive advantage. |
PDF Full Text Request